Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
continuous dosing
Description:
A medication regimen in which a drug is administered or taken continuously rather than at intervals, studied across clinical and veterinary contexts.
OpenAlex ID:
keywords/continuous-dosing
MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer
2017
·
Maura N. Dickler
, Sara M. Tolaney
, et al.
·
Clinical Cancer Research
·
726
PDF
Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
2011
·
Leena Gandhi
, D. Ross Camidge
, et al.
·
Journal of Clinical Oncology
·
674
Selective serotonin reuptake inhibitors for premenstrual syndrome
2013
·
Jane Marjoribanks
, Julie Brown
, et al.
·
Cochrane Database of Systematic Reviews
·
493
PDF
Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation
2010
·
Laurie L. Carr
, David A. Mankoff
, et al.
·
Clinical Cancer Research
·
443
First-in-Human Phase I Study of Pictilisib (GDC-0941), a Potent Pan–Class I Phosphatidylinositol-3-Kinase (PI3K) Inhibitor, in Patients with Advanced Solid Tumors
2014
·
Debashis Sarker
, Joo Ern Ang
, et al.
·
Clinical Cancer Research
·
394
Kinetics of antimicrobial activity
1986
·
Bennett Vogelman
, William A. Craig
·
The Journal of Pediatrics
·
355
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study
2014
·
Thomas Voit
, Haluk Topaloglu
, et al.
·
The Lancet Neurology
·
337
Long-term Weight Loss With Sibutramine: A Randomized Controlled Trial
2001
·
Alfred Wirth
, Jutta Krause
·
JAMA
·
292
Portable biosensor for monitoring cortisol in low-volume perspired human sweat
2017
·
David Kinnamon
, Ramesh Ghanta
, et al.
·
Scientific Reports
·
245
PDF
Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide–refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02
2013
·
Xavier Leleu
, Michel Attal
, et al.
·
Blood
·
222
Phase II Study of the Efficacy and Tolerability of Two Dosing Regimens of the Farnesyl Transferase Inhibitor, R115777, in Advanced Breast Cancer
2003
·
Stephen R.D. Johnston
, Tamas Hickish
, et al.
·
Journal of Clinical Oncology
·
208
Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial
2020
·
Jieqiong Liu
, Qiang Liu
, et al.
·
Journal for ImmunoTherapy of Cancer
·
201
PDF
Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial
2012
·
Leonard A Mattano
, Meenakshi Devidas
, et al.
·
The Lancet Oncology
·
190
Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies
2015
·
A.L. Wong
, R.A. Soo
, et al.
·
Annals of Oncology
·
188
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer
2016
·
Yvette Drew
, Jonathan Ledermann
, et al.
·
British Journal of Cancer
·
171
PDF
Selective Serotonin Reuptake Inhibitors for Premenstrual Syndrome and Premenstrual Dysphoric Disorder: A Meta-Analysis
2008
·
Nirav R. Shah
, J B. Jones
, et al.
·
Obstetrics and Gynecology
·
169
Acetaminophen for Chronic Pain: A Systematic Review on Efficacy
2015
·
Zandra Nymand Ennis
, Dorthe Dideriksen
, et al.
·
Basic & Clinical Pharmacology & Toxicology
·
156
PDF
Phase I Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors
2006
·
Charles Erlichman
, Manuel Hidalgo
, et al.
·
Journal of Clinical Oncology
·
153
PDF
A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study
2010
·
J.J. Biagi
, A.M. Oza
, et al.
·
Annals of Oncology
·
143
PDF
A Phase I Pharmacokinetic and Pharmacodynamic Study of TKI258, an Oral, Multitargeted Receptor Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors
2008
·
Debashis Sarker
, Rhoda Molife
, et al.
·
Clinical Cancer Research
·
143
PDF
Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets
2015
·
Kartik Sehgal
, Rituparna Das
, et al.
·
Blood
·
135
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial
2020
·
Alain P. Algazi
, Megan Othus
, et al.
·
Nature Medicine
·
129
A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis
1997
·
V. HAVU
, H. BRANDT
, et al.
·
British Journal of Dermatology
·
116
A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors
2014
·
Igor Puzanov
, Colin R. Lindsay
, et al.
·
Clinical Cancer Research
·
104
Enhancement of the Therapeutic Efficacy of Taxol by the Mitogen-Activated Protein Kinase Kinase Inhibitor CI-1040 in Nude Mice Bearing Human Heterotransplants
2005
·
Hayley M. McDaid
, Lluis Lopez-Barcons
, et al.
·
Cancer Research
·
100
PDF
Show more works
View as search
Works count:
756
Citation count:
13,360
Year
Topic
Type